You have 9 free searches left this month | for more free features.

Condition

Hepatocellular Carcinoma (2)

Non-alcoholic Steatohepatitis (NASH) (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Can-Fite BioPharma (3)

Collaborator

Intervention

cf102 (3)

placebo (2)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

cf102

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatocellular Carcinoma Trial in Worldwide (CF102, Placebo)

Completed

Hepatocellular Carcinoma

CF102
Placebo

Aurora, Colorado
+20 more

Mar 7, 2022

Non-alcoholic Steatohepatitis (NASH) Trial in Jerusalem, Nazareth, Petach Tikva (CF102, Placebo)

Completed

Non-alcoholic Steatohepatitis (NASH)

CF102
Placebo

Jerusalem, Israel
+2 more

Mar 16, 2020

Hepatocellular Carcinoma Trial in Tel Aviv (CF102)

Completed

Hepatocellular Carcinoma

CF102

Tel Aviv, Israel

Rabin Medical Center

Feb 26, 2015